Author details

Full Name

Pravin J Mishra

Affiliation

Robert Wood Johnson Medical School, The State University of New Jersey

ORCID

Career Start Year

2007

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36513925	Visualizing Activated Myofibroblasts Resulting from Differentiation of Mesenchymal Stem Cells.	Methods Mol Biol	2023
36513925	Visualizing Activated Myofibroblasts Resulting from Differentiation of Mesenchymal Stem Cells.	Methods Mol Biol	2023
31949145	Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis.	Nat Commun	2020
31949145	Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis.	Nat Commun	2020
27601506	A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs.	J Oncol Pract	2017
27601506	A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs.	J Oncol Pract	2017
28185193	Activation and Differentiation of Mesenchymal Stem Cells.	Methods Mol Biol	2017
28185193	Activation and Differentiation of Mesenchymal Stem Cells.	Methods Mol Biol	2017
27294075	Keratinocyte Induced Differentiation of Mesenchymal Stem Cells into Dermal Myofibroblasts: A Role in Effective Wound Healing.	Int J Transl Sci	2016
27294075	Keratinocyte Induced Differentiation of Mesenchymal Stem Cells into Dermal Myofibroblasts: A Role in Effective Wound Healing.	Int J Transl Sci	2016
27846237	Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy.	PLoS One	2016
27846237	Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy.	PLoS One	2016
25524638	p53 loss increases the osteogenic differentiation of bone marrow stromal cells.	Stem Cells	2015
25629959	Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.	PLoS Genet	2015
25524638	p53 loss increases the osteogenic differentiation of bone marrow stromal cells.	Stem Cells	2015
25629959	Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.	PLoS Genet	2015
24267888	A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway.	Cell	2013
24267888	A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway.	Cell	2013
22993660	Cell-free derivatives from mesenchymal stem cells are effective in wound therapy.	World J Stem Cells	2012
22993660	Cell-free derivatives from mesenchymal stem cells are effective in wound therapy.	World J Stem Cells	2012
20309934	Transformation of benign Barrett's epithelium by repeated acid and bile exposure over 65 weeks: a novel in vitro model.	Int J Cancer	2011
21370035	Activation and differentiation of mesenchymal stem cells.	Methods Mol Biol	2011
20309934	Transformation of benign Barrett's epithelium by repeated acid and bile exposure over 65 weeks: a novel in vitro model.	Int J Cancer	2011
20628066	Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy.	J Leukoc Biol	2011
21370035	Activation and differentiation of mesenchymal stem cells.	Methods Mol Biol	2011
20628066	Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy.	J Leukoc Biol	2011
20633553	Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu.	Exp Cell Res	2010
20633553	Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu.	Exp Cell Res	2010
19208837	Mesenchymal stem cells: flip side of the coin.	Cancer Res	2009
19208837	Mesenchymal stem cells: flip side of the coin.	Cancer Res	2009
20041160	MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.	PLoS One	2009
20003889	Translational modulation of proteins expressed from bicistronic vectors.	Mol Imaging	2009
20041160	MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.	PLoS One	2009
20003889	Translational modulation of proteins expressed from bicistronic vectors.	Mol Imaging	2009
18414050	MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics.	Cell Cycle	2008
18519693	Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells.	Cancer Res	2008
18414050	MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics.	Cell Cycle	2008
18722367	The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells.	Exp Cell Res	2008
18722367	The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells.	Exp Cell Res	2008
18519693	Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells.	Cancer Res	2008
17686970	A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance.	Proc Natl Acad Sci U S A	2007
17665987	The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy.	Expert Opin Biol Ther	2007
17665987	The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy.	Expert Opin Biol Ther	2007
17686970	A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance.	Proc Natl Acad Sci U S A	2007

1 - 44 of 44

Mara Gilardi

Institute of Medical Genetics and Pathology.

Career Start Year 2014

Number of shared co-authors 1

Radek Fedr

Institute of Biophysics of the Czech Academy of Sciences

Career Start Year 2013

Number of shared co-authors 0

Daniel J McGrail

Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic

Career Start Year 2012

Number of shared co-authors 0

Giuseppina Claps

Institut National de la Sante et de la Recherche Medicale (INSERM) U

Career Start Year 2010

Number of shared co-authors 3

Michael P O'Connell

National Institute of Allergy and Infectious Diseases, National Institutes of Health

Career Start Year 2007

Number of shared co-authors 4

Aparna Jayachandran

The University of Queensland

Career Start Year 2007

Number of shared co-authors 0

Anandaroop Mukhopadhyay

National University Hospital

Career Start Year 2005

Number of shared co-authors 0

Nehad M Alajez

College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation

Career Start Year 2004

Number of shared co-authors 0

Susan E Zabierowski

Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center

Career Start Year 2002

Number of shared co-authors 1

Susan L Woods

Adelaide Medical School, University of Adelaide

Career Start Year 2002

Number of shared co-authors 4

Trevor D McKee

University Health Network

Career Start Year 2001

Number of shared co-authors 0

Beate Rinner

Medical University of Graz

Career Start Year 2000

Number of shared co-authors 0

Qingxia Wei

Princess Margaret Cancer Centre, University Health Network and University of Toronto

Career Start Year 2000

Number of shared co-authors 0

Roya Navab

Princess Margaret Cancer Centre, University Health Network

Career Start Year 1997

Number of shared co-authors 0

Fernando Lecanda

University of Navarra, Center for Applied Medical Research

Career Start Year 1995

Number of shared co-authors 4

Jan Paul Medema

Oncode Institute

Career Start Year 1993

Number of shared co-authors 0

Ashani T Weeraratna

Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine

Career Start Year 1992

Number of shared co-authors 13

Marcus Bosenberg

Yale School of Medicine

Career Start Year 1992

Number of shared co-authors 15

Cun-Yu Wang

University of California, Los Angeles (university of california los angeles)

Career Start Year 1991

Number of shared co-authors 0

Laurie Ailles

University of Toronto

Career Start Year 1991

Number of shared co-authors 1

Fabio M V Rossi

University of British Columbia

Career Start Year 1990

Number of shared co-authors 0

Frank C Marini

Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine

Career Start Year 1990

Number of shared co-authors 2

Roger Chammas

Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo

Career Start Year 1989

Number of shared co-authors 0

William L Stanford

Ottawa Hospital Research Institute

Career Start Year 1989

Number of shared co-authors 0

William Matsui

Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin

Career Start Year 1989

Number of shared co-authors 0

Enzo Medico

Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS

Career Start Year 1988

Number of shared co-authors 0

Valerie M Weaver

University of California san francisco

Career Start Year 1988

Number of shared co-authors 0

Louis Gaboury

Institute for Research in Immunology and Cancer (IRIC), University of Montreal

Career Start Year 1986

Number of shared co-authors 0

Menashe Bar-Eli

The University of Texas MD Anderson Cancer Center

Career Start Year 1975

Number of shared co-authors 1

Meenhard Herlyn

Ellen and Ronald Caplan Cancer Center, The Wistar Institute

Career Start Year 1972

Number of shared co-authors 10

row(s) 1 - 30 of 30

Glenn Merlino

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 6

Theresa Guo

Moores Cancer Center, University of California

Co-authored papers 3

Paul S Meltzer

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 3

Susan R Davis

Co-authored papers 3

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Co-authored papers 3

Maxwell P Lee

National Cancer Institute, National Institutes of Health

Co-authored papers 2

Howard H Yang

Center for Cancer Research, National Cancer Institute

Co-authored papers 2

M Raza Zaidi

Northwell Health Cancer Institute

Co-authored papers 2

Richard A Sturm

Frazer Institute, The University of Queensland, Dermatology Research Centre